Showing results (221-230 of 22,075) with videos related to
Sort By:
Pageof 2,208
Oncogene|October 17, 2018
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative diseaseEbru Aydin, Alexander Hallner, Hanna Grauers Wiktorin, et al.Oncogene|February 12, 1998
Activation of the c-fos SRE through SAP-1aH Masutani, L Magnaghi-Jaulin, S Ait-Si-Ali, et al.Oncogene|February 12, 1998
Evidence of genetic progression in human gastric carcinomas with microsatellite instabilityY J Chung, S W Park, J M Song, et al.Oncogene|October 7, 1997
Phosphorylation of the Src substrate Sam68 by Cdc2 during mitosisR J Resnick, S J Taylor, Q Lin, et al.Oncogene|October 7, 1997
Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinaseT Oda, J Kujovich, M Reis, et al.Oncogene|October 7, 1997
High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiationA Bounacer, R Wicker, B Caillou, et al.Oncogene|October 7, 1997
Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell linesE C Lerner, T T Zhang, D B Knowles, et al.Oncogene|October 7, 1997
Characterization of a highly conserved gene (OS4) amplified with CDK4 in human sarcomasY A Su, M M Lee, C M Hutter, et al.Oncogene|October 7, 1997
A novel protein with strong homology to the tumor suppressor p53H Schmale, C BambergerOncogene|August 7, 1997
Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesisW C Weinberg, N E Montano, C DengPageof 2,208